These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 5856135)

  • 1. Studies on the "hypercoagulable state".
    Galewski K; Izak G; Eyal Z
    Isr J Med Sci; 1965 Jul; 1(4):865. PubMed ID: 5856135
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on experimentally induced hypercoagulable state in rabbits.
    Izak G; Galewsky K
    Thromb Diath Haemorrh; 1966 Jul; 16(1):228-42. PubMed ID: 5989043
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on thromboplastin activity, fibrinolysis and uptake of radioactive iodine-labeled fibrinogen in various experimental tumors].
    Hilgard P; Heyes H; Sigmund E; Hiemeyer V
    Fortschr Geb Rontgenstr Nuklearmed; 1970 Jul; 113(1):96-100. PubMed ID: 5534016
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on hypercoagulable state. II. The application of 131I-labelled fibrinogen for the estimation of intravascular coagulation in human subjects.
    Izak G; Galewski K; Eyal Z
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):544-51. PubMed ID: 5590243
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinogen turnover after massive haemorrhage in heparinized dogs.
    Leandoer L; Appelgren L; Bergentz SE
    Eur Surg Res; 1969; 1(2):115-25. PubMed ID: 5406435
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism and distribution of fibrinogen. I. Fibrinogen turnover in physiological conditions in humans.
    Collen D; Tytgat GN; Claeys H; Piessens R
    Br J Haematol; 1972 Jun; 22(6):681-700. PubMed ID: 5064500
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the hypercoagulable state. The regulation of fibrinogen production in experimental hyper- and hypofibrinogenemia.
    Kropatkin ML; Izak G
    Thromb Diath Haemorrh; 1968 Jul; 19(3):547-55. PubMed ID: 5708132
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of fats on blood coagulation and fibrinolysis.
    Meuwissen OJ; Hart HC; van Hemel-Rupert MS
    Thromb Diath Haemorrh; 1968 Mar; 19(1):267-78. PubMed ID: 5652234
    [No Abstract]   [Full Text] [Related]  

  • 9. [Proceedings: 71. Changes of fibrinogen turn over rate by fibrinolysis (author's transl)].
    Sugie I; Hishikawa Y; Nitta H
    Nihon Seirigaku Zasshi; 1973; 35(8):411. PubMed ID: 4799272
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in anticoagulant properties of the blood following autosensitization].
    Maianskiĭ DN
    Vopr Med Khim; 1965; 11(4):24-7. PubMed ID: 5873836
    [No Abstract]   [Full Text] [Related]  

  • 12. Biomarkers of altered coagulation and fibrinolysis as measures of disease activity in active inflammatory bowel disease: a gender-stratified, cohort analysis.
    Shen J; Ran ZH; Zhang Y; Cai Q; Yin HM; Zhou XT; Xiao SD
    Thromb Res; 2009 Feb; 123(4):604-11. PubMed ID: 18499234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring the coagulability of fibrinogen in plasma by isotopic means. Method and principles of its use for in vivo studies.
    Regoeczi E
    Thromb Diath Haemorrh; 1967 Aug; 18(1-2):276-85. PubMed ID: 4169265
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thrombocyte function and problems of blood coagulation and fibrinolysis in head and neck cancer].
    Noda Y; Sueno K; Kosugi T; Franke KD
    HNO; 1984 Apr; 32(4):177-9. PubMed ID: 6725025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent knowledge on blood coagulation and fibrinolysis; measurement of coagulation dynamics in vivo.
    Izak G
    Isr J Med Sci; 1965 Jul; 1(4):655-63. PubMed ID: 5842281
    [No Abstract]   [Full Text] [Related]  

  • 16. [Distribution of fibrinogen I-131 in acute fibrinolysis caused by the administration of streptase].
    Malysheva AIu
    Probl Gematol Pereliv Krovi; 1971 Jun; 16(6):23-7. PubMed ID: 4256157
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in the coagulation and anti-coagulation systems of the blood under the influence of nicotinic acid].
    Kiseleva LN; Romanenko GK
    Klin Med (Mosk); 1966 Jan; 44(1):48-50. PubMed ID: 5988141
    [No Abstract]   [Full Text] [Related]  

  • 18. Occurrence of soluble very high molecular weight fibrinogen complexes in hypercoagulable states. An in vitro and in vivo study on their features.
    Neri Serneri GG; Gensini GF; Abbate R; Favilla S
    Thromb Haemost; 1980 Feb; 42(5):1561-73. PubMed ID: 6768154
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of blood coagulation and fibrinolysis by polyamines in the presence of glycosaminoglycans.
    Homma R; Mase A; Toida T; Kashiwagi K; Igarashi K
    Int J Biochem Cell Biol; 2005 Sep; 37(9):1911-20. PubMed ID: 15936241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood coagulation and fibrinolysis in experimental nephritis].
    Kawai T; Hasegawa H; Kakizaki H; Watanabe N; Murao M
    Saishin Igaku; 1968 Nov; 23(11):2449-53. PubMed ID: 5715174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.